Stock Earnings

Question 1

Phathom Pharmaceuticals Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Phathom Pharmaceuticals Inc의 총 자산은 $378이며, 순loss입니다.

Question 2

PHAT의 주요 재무 비율은 무엇인가요?

Accepted Answer

Phathom Pharmaceuticals Inc의 유동비율은 0.59이고, 순이익률은 -607.27, 주당 매출은 $0.87입니다.

Question 3

Phathom Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Phathom Pharmaceuticals Inc largest revenue segment is Vonoprazan, at a revenue of 55,252,000 in the most earnings release.For geography, United States is the primary market for Phathom Pharmaceuticals Inc, at a revenue of 55,252,000.

Question 4

Phathom Pharmaceuticals Inc은 수익성이 있나요?

Accepted Answer

no, 최신 재무제표에 따르면 Phathom Pharmaceuticals Inc의 순loss은 $-334입니다.

Question 5

Phathom Pharmaceuticals Inc에 부채가 있나요?

Accepted Answer

yes, Phathom Pharmaceuticals Inc의 부채는 631입니다.

Question 6

Phathom Pharmaceuticals Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Phathom Pharmaceuticals Inc의 총 발행 주식은 68.51주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	147	55	0	0	0	0
Revenue Growth (YoY)	465%	--	--	--	--	--
Cost of Revenue	18	7	0	--	--	--
Gross Profit	128	47	0	--	--	--
Selling, General & Admin	308	290	117	101	62	27
Research & Development	33	34	49	71	72	98
Operating Expenses	341	324	167	172	135	125
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-274	-334	-201	-197	-143	-129
Income Tax Expense	--	--	--	--	--	--
Net Income	-274	-334	-201	-197	-143	-129
Net Income Growth	-19%	66%	2%	38%	11%	-49%
Shares Outstanding (Diluted)	73.39	63.17	51.28	39.12	30.51	33.23
Shares Change (YoY)	14%	23%	31%	28%	-8%	34%
EPS (Diluted)	-3.74	-5.29	-3.93	-5.05	-4.72	-3.88
EPS Growth	-28.99%	35%	-22%	7%	22%	-62%
Free Cash Flow	-225	-266	-139	-147	-148	-70
Free Cash Flow Per Share	-3.06	-4.21	-2.71	-3.75	-4.85	-2.1
Gross Margin	87.07%	85.45%	0%	--	--	--
Operating Margin	-144.89%	-503.63%	0%	0%	0%	0%
Profit Margin	-186.39%	-607.27%	0%	0%	0%	0%
Free Cash Flow Margin	-153.06%	-483.63%	0%	0%	0%	0%
EBITDA	-213	-277	-167	-172	-135	-125
EBITDA Margin	-144.89%	-503.63%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-213	-277	-167	-172	-135	-125
EBIT Margin	-144.89%	-503.63%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Phathom Pharmaceuticals Inc (PHAT) Price

PHAT Stock Price Chart

PHAT Income

Follow-Up Questions